IL-4, IgM, and resistance to BTKi and PI3Kδi in CLL.
作者： Simon D. Wagner
DOI: 10.1182/BLOOD-2016-04-708180
关键词:
摘要: In this issue of Blood , [Aguilar-Hernandez et al][1][1][2] refine our understanding the mechanism action interleukin 4 (IL-4) in promoting B-cell receptor (BCR)-mediated signaling primary human chronic lymphocytic leukemia (CLL) and resistance to a Bruton tyrosine kinase inhibitor (BTKi
ashpublications.org
bloodjournal.org参考文章(10)
Meike Burger, Tanja Hartmann, Myriam Krome, Justyna Rawluk, Hirokazu Tamamura, Nobutaka Fujii, Thomas J. Kipps, Jan A. Burger, Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells Blood. ,vol. 106, pp. 1824- 1830 ,(2005) , 10.1182/BLOOD-2004-12-4918
Gloria Lutzny, Thomas Kocher, Marc Schmidt-Supprian, Martina Rudelius, Ludger Klein-Hitpass, Andrew J Finch, Jan Dürig, Michaela Wagner, Claudia Haferlach, Alexander Kohlmann, Susanne Schnittger, Marc Seifert, Stefan Wanninger, Nadja Zaborsky, Robert Oostendorp, Jürgen Ruland, Michael Leitges, Toni Kuhnt, Yvonne Schäfer, Benedikt Lampl, Christian Peschel, Alexander Egle, Ingo Ringshausen, None, Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo Cancer Cell. ,vol. 23, pp. 77- 92 ,(2013) , 10.1016/J.CCR.2012.12.003
William E. Paul, History of interleukin-4. Cytokine. ,vol. 75, pp. 3- 7 ,(2015) , 10.1016/J.CYTO.2015.01.038
Elisa ten Hacken, Jan A. Burger, Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies. Pharmacology & Therapeutics. ,vol. 144, pp. 338- 348 ,(2014) , 10.1016/J.PHARMTHERA.2014.07.003
Xiao-Jie Yan, Steven L. Allen, Jonathan E. Kolitz, Sivasubramanian Baskar, Christoph Rader, Hakan Mellstedt, Hodjattallah Rabbani, Annette Lee, Peter K. Gregersen, Kanti R. Rai, Nicholas Chiorazzi, Davide Bagnara, Matthew S. Kaufman, Carlo Calissano, Sonia Marsilio, Piers E. M. Patten, Rita Simone, Philip Chum, A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease Blood. ,vol. 117, pp. 5463- 5472 ,(2011) , 10.1182/BLOOD-2010-12-324210
T. L. Rothstein, B. Guo, Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin Journal of Internal Medicine. ,vol. 265, pp. 632- 643 ,(2009) , 10.1111/J.1365-2796.2009.02103.X
Benchang Guo, Thomas L. Rothstein, IL-4 Upregulates Igα and Igβ Protein, Resulting in Augmented IgM Maturation and B Cell Receptor–Triggered B Cell Activation Journal of Immunology. ,vol. 191, pp. 670- 677 ,(2013) , 10.4049/JIMMUNOL.1203211
S-S Chen, B Y Chang, S Chang, T Tong, S Ham, B Sherry, J A Burger, K R Rai, N Chiorazzi, BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia. Leukemia. ,vol. 30, pp. 833- 843 ,(2016) , 10.1038/LEU.2015.316
Manoj K. Kashyap, Deepak Kumar, Harrison Jones, Carlos I. Amaya-Chanaga, Michael Y. Choi, Johanna Melo-Cardenas, Amine Ale-Ali, Michelle R. Kuhne, Peter Sabbatini, Lewis J. Cohen, Suresh G. Shelat, Laura Z. Rassenti, Thomas J. Kipps, Pina M. Cardarelli, Januario E. Castro, Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway Oncotarget. ,vol. 7, pp. 2809- 2822 ,(2016) , 10.18632/ONCOTARGET.6465
Maria M. Aguilar-Hernandez, Matthew D. Blunt, Rachel Dobson, Alison Yeomans, Stephen Thirdborough, Marta Larrayoz, Lindsay D. Smith, Adam Linley, Jonathan C. Strefford, Andrew Davies, Peter M. W. Johnson, Natalia Savelyeva, Mark S. Cragg, Francesco Forconi, Graham Packham, Freda K. Stevenson, Andrew J. Steele, IL-4 enhances expression and function of surface IgM in CLL cells. Blood. ,vol. 127, pp. 3015- 3025 ,(2016) , 10.1182/BLOOD-2015-11-682906